These studies independently confirm roles for β-cat in the upregulation of key anti-inflammatory mediators, such as IL-10 and TGFβ, as well as tolerogenic T-cell behaviors relevant to tumor immunosuppression and inflammatory bowel disease (76, 77). Here, IL10 is linked to neoplasm.